Some effector CD4+ T cell subsets display cytotoxic activity, thus breaking the functional dichotomy of CD4+ helper and CD8+ cytotoxic T lymphocytes. However, molecular mechanisms regulating CD4+ cytotoxic T lymphocyte (CD4+ CTL) differentiation are poorly understood. Here we show that levels of histone deacetylases 1 and 2 (HDAC1-HDAC2) are key determinants of CD4+ CTL differentiation. Deletions of both Hdac1 and 1 Hdac2 alleles (HDAC1cKO-HDAC2HET) in CD4+ T cells induced a T helper cytotoxic program that was controlled by IFN-γ–JAK1/2–STAT1 signaling. In vitro, activated HDAC1cKO-HDAC2HET CD4+ T cells acquired cytolytic activity and displayed enrichment of gene signatures characteristic of effector CD8+ T cells and human CD4+ CTLs. In vivo, murine cytomegalovirus–infected HDAC1cKO-HDAC2HET mice displayed a stronger induction of CD4+ CTL features compared with infected WT mice. Finally, murine and human CD4+ T cells treated with short-chain fatty acids, which are commensal-produced metabolites acting as HDAC inhibitors, upregulated CTL genes. Our data demonstrate that HDAC1-HDAC2 restrain CD4+ CTL differentiation. Thus, HDAC1-HDAC2 might be targets for the therapeutic induction of CD4+ CTLs.
Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier
Title and authors | Publication | Year |
---|---|---|
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Peng S, Lin A, Jiang A, Zhang C, Zhang J, Cheng Q, Luo P, Bai Y |
Molecular Cancer | 2024 |
Microbial metabolite-guided CAR T cell engineering enhances anti-tumor immunity via epigenetic-metabolic crosstalk.
Staudt S, Nikolka F, Perl M, Franz J, Leblay N, Yuan XK, Warmuth L, Fantes MA, Skorupskaitė A, Fei T, Bromberg M, Martin-Uriz PS, Rodriguez-Madoz JR, Ziegler-Martin K, Gholam NA, Benz P, Tran PH, Freitag F, Riester Z, Stein-Thoeringer C, Schmitt M, Kleigrewe K, Weber J, Mangold K, Einsele H, Prosper F, Ellmeier W, Busch D, Visekruna A, Slingerland J, Shouval R, Hiller K, van den Brink M, Pausch P, Neri P, Hudecek M, Poeck H, Luu M |
bioRxiv : the preprint server for biology | 2024 |
Epigenetic Perspective of Immunotherapy for Cancers
Keshari S, Barrodia P, Singh AK |
Cells | 2023 |
COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape
Ghosh MK, Kumar S, Ganguly KK, Ghosh P, Tabassum S, Basu B, Basu M |
Epigenomics | 2023 |
Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State
Y Li, Z Ye, J Zhu, S Fang, L Meng, C Zhou |
Frontiers in immunology | 2022 |
Role of Histone Deacetylases in T-Cell Development and Function.
Pieniawska M, Iżykowska K |
International journal of molecular sciences | 2022 |
Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions
Jotereau F, Alameddine J, Teusan R, Pédron A, Jouand N, Altare F, Godefroy E |
Frontiers in immunology | 2022 |
Epigenetic strategies to boost CAR T cell therapy
B Akbari, N Ghahri-Saremi, T Soltantoyeh, J Hadjati, S Ghassemi, HR Mirzaei |
Molecular Therapy | 2021 |
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
M Saillard, M Cenerenti, P Romero, C Jandus |
Human vaccines | 2021 |
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
A Cachot, M Bilous, YC Liu, X Li, M Saillard, M Cenerenti, GA Rockinger, T Wyss, P Guillaume, J Schmidt, R Genolet, G Ercolano, MP Protti, W Reith, K Ioannidou, L de Leval, JA Trapani, G Coukos, A Harari, DE Speiser, A Mathis, D Gfeller, H Altug, P Romero, C Jandus |
Science Advances | 2021 |
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
M Luu, Z Riester, A Baldrich, N Reichardt, S Yuille, A Busetti, M Klein, A Wempe, H Leister, H Raifer, F Picard, K Muhammad, K Ohl, R Romero, F Fischer, CA Bauer, M Huber, TM Gress, M Lauth, S Danhof, T Bopp, T Nerreter, IE Mulder, U Steinhoff, M Hudecek, A Visekruna |
Nature Communications | 2021 |
Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a
F Li, D Wang, H Wang, L Chen, X Sun, Y Wan |
Respiratory Research | 2021 |
Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
S Kim, S Santhanam, S Lim, J Choi |
International journal of molecular sciences | 2020 |
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
G Li, Y Tian, WG Zhu |
Frontiers in Cell and Developmental Biology | 2020 |
Annona muricata L.-Derived Polysaccharides as a Potential Adjuvant to a Dendritic Cell-Based Vaccine in a Thymoma-Bearing Model
WS Kim, JM Han, HY Song, EH Byun, ST Lim, EB Byun |
Nutrients | 2020 |
Recent Update of HDAC Inhibitors in Lymphoma
IC Chen, B Sethy, JP Liou |
Frontiers in Cell and Developmental Biology | 2020 |